Clinical studies recruiting near Salt Lake City

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Randomized Trial of SGLT2i in Heart Transplant Recipients
Phase 4 · VA Salt Lake City Health Care System, Salt Lake City, UT · VA Office of Research and Development · NCT06625073 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Amgen · NCT07037433 Muscle Blood Flow Regulation in HFpEF
NA · VA Salt Lake City Health Care System, Salt Lake City, UT · VA Office of Research and Development · NCT05115890 CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
NA · VA Salt Lake City Health Care System, Salt Lake City, UT · VA Office of Research and Development · NCT05996328 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Utah Cancer Specialists-Salt Lake City · NRG Oncology · NCT05174169 A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Phase 3 · Eli Lilly and Company · NCT06672549 Evaluation of the Excretion of Suzetrigine Into Breast Milk in Healthy Lactating Female Participants
Phase 1 · ICON - Utah - Salt Lake City Office · Vertex Pharmaceuticals Incorporated · NCT07378865 Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Phase 1 · ICON Clinical Research: Salt Lake City · Shionogi · NCT07093580 Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adoles
Phase 3 · Pfizer · NCT07660198 WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Phase 2 · WISPer Site in Salt Lake City, UT · Mediar Therapeutics · NCT06967805 A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission o
Phase 3 · Hoffmann-La Roche · NCT06094010 SELUTION 4 De Novo Small Vessel IDE Trial
NA · M.A. Med Alliance S.A. · NCT05946629 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Utah Cancer Specialists-Salt Lake City · NRG Oncology · NCT04852887 Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Phase 4 · VA Salt Lake City Health Care System, Salt Lake City, UT · VA Office of Research and Development · NCT02915198 Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
NA · Salt Lake City VA · The University of Texas Health Science Center at San Antonio · NCT07176273 Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease
Phase N/A · University of Utah Health Sciences Center · University of Utah · NCT01099982 S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic
NA · Utah Cancer Specialists-Salt Lake City · SWOG Cancer Research Network · NCT03723928 Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Phase 4 · University of Utah · Duke University · NCT04262206 A Phase 1, First-in-human Study of VX-433
Phase 1 · ICON - Utah - Salt Lake City Office · Vertex Pharmaceuticals Incorporated · NCT07584434 Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
Phase 4 · Velocity Clinical- Salt Lake City · Alimentiv Inc. · NCT06997965 Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Phase 3 · Utah Cancer Specialists-Salt Lake City · ECOG-ACRIN Cancer Research Group · NCT03937635 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Utah Cancer Specialists-Salt Lake City · SWOG Cancer Research Network · NCT03851445 A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.
Phase 3 · Bavarian Nordic · NCT07003984 Ca-Mg Butyrate in GWI
Phase 2 · VA Salt Lake City Health Care System, Salt Lake City, UT · VA Office of Research and Development · NCT05367245 Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Phase 2 · Care Access - Salt Lake City /ID# 266785 · AbbVie · NCT06548542 Novel Approaches for Improving Vascular Function in Veterans With HFpEF
Phase 1 · VA Salt Lake City Health Care System, Salt Lake City, UT · VA Office of Research and Development · NCT06312748 Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial
Phase 3 · VA Salt Lake City Health Care System, Salt Lake City, UT · VA Office of Research and Development · NCT07218354 A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uteri
Phase 3 · Salt Lake City · Sumitomo Pharma Switzerland GmbH · NCT05862272 Study of DONQ52 in Active Celiac Disease
Phase 2 · Chugai Pharmaceutical · NCT07239336 Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts
Phase 2/Phase 3 · University of Utah Midvalley Health Center · Western Institute for Veterans Research · NCT05625633

Look up another city

Look up another condition